HEADER HYDROLASE 06-MAY-22 7XPY TITLE CRYSTAL STRUCTURE OF USP7 IN COMPLEX WITH ITS INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 560-1102; COMPND 5 SYNONYM: DEUBIQUITINATING ENZYME 7,HERPESVIRUS-ASSOCIATED UBIQUITIN- COMPND 6 SPECIFIC PROTEASE,UBIQUITIN THIOESTERASE 7,UBIQUITIN-SPECIFIC- COMPND 7 PROCESSING PROTEASE 7; COMPND 8 EC: 3.4.19.12; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: USP7, HAUSP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-1 KEYWDS INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN-SPECIFIC PROTEASE, KEYWDS 2 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR N.FENG,K.W.ZENG REVDAT 2 29-NOV-23 7XPY 1 REMARK REVDAT 1 24-AUG-22 7XPY 0 JRNL AUTH X.W.ZHANG,N.FENG,Y.C.LIU,Q.GUO,J.K.WANG,Y.Z.BAI,X.M.YE, JRNL AUTH 2 Z.YANG,H.YANG,Y.LIU,M.M.YANG,Y.H.WANG,X.M.SHI,D.LIU,P.F.TU, JRNL AUTH 3 K.W.ZENG JRNL TITL NEUROINFLAMMATION INHIBITION BY SMALL-MOLECULE TARGETING JRNL TITL 2 USP7 NONCATALYTIC DOMAIN FOR NEURODEGENERATIVE DISEASE JRNL TITL 3 THERAPY. JRNL REF SCI ADV V. 8 O0789 2022 JRNL REFN ESSN 2375-2548 JRNL PMID 35947662 JRNL DOI 10.1126/SCIADV.ABO0789 REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.74 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.840 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 40042 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.226 REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 2012 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.7400 - 5.6584 0.99 2874 152 0.1886 0.2081 REMARK 3 2 5.6584 - 4.4934 1.00 2762 149 0.1813 0.2244 REMARK 3 3 4.4934 - 3.9260 1.00 2752 146 0.1978 0.2248 REMARK 3 4 3.9260 - 3.5673 1.00 2731 144 0.2257 0.3097 REMARK 3 5 3.5673 - 3.3118 1.00 2720 140 0.2538 0.2925 REMARK 3 6 3.3118 - 3.1166 1.00 2684 146 0.2561 0.2649 REMARK 3 7 3.1166 - 2.9606 1.00 2721 138 0.2755 0.3487 REMARK 3 8 2.9606 - 2.8318 1.00 2698 148 0.2773 0.3609 REMARK 3 9 2.8318 - 2.7228 1.00 2675 144 0.2805 0.3297 REMARK 3 10 2.7228 - 2.6288 1.00 2690 138 0.2781 0.3395 REMARK 3 11 2.6288 - 2.5467 1.00 2680 142 0.2886 0.3515 REMARK 3 12 2.5467 - 2.4739 1.00 2672 143 0.3058 0.3806 REMARK 3 13 2.4739 - 2.4088 1.00 2679 146 0.3111 0.3833 REMARK 3 14 2.4088 - 2.3500 1.00 2692 136 0.3296 0.3762 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.560 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 60.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 80.33 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7XPY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1300029359. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-DEC-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97891 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40115 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.350 REMARK 200 RESOLUTION RANGE LOW (A) : 44.920 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.43 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 2YLM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2% V/V TACSIMATE PH 7.0, 0.1 M REMARK 280 IMIDAZOLE PH 7.0, 8% W/V POLYETHYLENE GLYCOL 3350, 5% V/V 2- REMARK 280 PROPANOL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 39.00250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.42850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.08500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 75.42850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 39.00250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.08500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 671 REMARK 465 SER A 672 REMARK 465 ALA A 1085 REMARK 465 PRO A 1086 REMARK 465 LYS A 1087 REMARK 465 ARG A 1088 REMARK 465 SER A 1089 REMARK 465 ARG A 1090 REMARK 465 TYR A 1091 REMARK 465 THR A 1092 REMARK 465 TYR A 1093 REMARK 465 LEU A 1094 REMARK 465 GLU A 1095 REMARK 465 LYS A 1096 REMARK 465 ALA A 1097 REMARK 465 ILE A 1098 REMARK 465 LYS A 1099 REMARK 465 ILE A 1100 REMARK 465 HIS A 1101 REMARK 465 ASN A 1102 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 582 -157.03 67.24 REMARK 500 GLU A 641 34.29 -90.25 REMARK 500 PRO A 667 -0.54 -57.10 REMARK 500 LEU A 813 -169.43 -126.53 REMARK 500 ASN A 831 66.32 60.57 REMARK 500 LEU A 836 35.60 -97.96 REMARK 500 TYR A 845 -58.39 -127.68 REMARK 500 SER A 967 -4.61 83.97 REMARK 500 ASP A 981 82.01 -150.11 REMARK 500 LYS A 997 -64.44 61.67 REMARK 500 ASP A1029 92.48 63.34 REMARK 500 GLN A1031 142.86 -39.82 REMARK 500 MET A1045 57.39 37.43 REMARK 500 GLU A1055 88.87 -155.59 REMARK 500 HIS A1081 -146.04 -131.44 REMARK 500 ASN A1083 -146.29 -94.51 REMARK 500 REMARK 500 REMARK: NULL DBREF 7XPY A 560 1102 UNP Q93009 UBP7_HUMAN 560 1102 SEQADV 7XPY GLY A 555 UNP Q93009 EXPRESSION TAG SEQADV 7XPY PRO A 556 UNP Q93009 EXPRESSION TAG SEQADV 7XPY LEU A 557 UNP Q93009 EXPRESSION TAG SEQADV 7XPY GLY A 558 UNP Q93009 EXPRESSION TAG SEQADV 7XPY SER A 559 UNP Q93009 EXPRESSION TAG SEQRES 1 A 548 GLY PRO LEU GLY SER GLU ALA HIS LEU TYR MET GLN VAL SEQRES 2 A 548 GLN ILE VAL ALA GLU ASP GLN PHE CYS GLY HIS GLN GLY SEQRES 3 A 548 ASN ASP MET TYR ASP GLU GLU LYS VAL LYS TYR THR VAL SEQRES 4 A 548 PHE LYS VAL LEU LYS ASN SER SER LEU ALA GLU PHE VAL SEQRES 5 A 548 GLN SER LEU SER GLN THR MET GLY PHE PRO GLN ASP GLN SEQRES 6 A 548 ILE ARG LEU TRP PRO MET GLN ALA ARG SER ASN GLY THR SEQRES 7 A 548 LYS ARG PRO ALA MET LEU ASP ASN GLU ALA ASP GLY ASN SEQRES 8 A 548 LYS THR MET ILE GLU LEU SER ASP ASN GLU ASN PRO TRP SEQRES 9 A 548 THR ILE PHE LEU GLU THR VAL ASP PRO GLU LEU ALA ALA SEQRES 10 A 548 SER GLY ALA THR LEU PRO LYS PHE ASP LYS ASP HIS ASP SEQRES 11 A 548 VAL MET LEU PHE LEU LYS MET TYR ASP PRO LYS THR ARG SEQRES 12 A 548 SER LEU ASN TYR CYS GLY HIS ILE TYR THR PRO ILE SER SEQRES 13 A 548 CYS LYS ILE ARG ASP LEU LEU PRO VAL MET CYS ASP ARG SEQRES 14 A 548 ALA GLY PHE ILE GLN ASP THR SER LEU ILE LEU TYR GLU SEQRES 15 A 548 GLU VAL LYS PRO ASN LEU THR GLU ARG ILE GLN ASP TYR SEQRES 16 A 548 ASP VAL SER LEU ASP LYS ALA LEU ASP GLU LEU MET ASP SEQRES 17 A 548 GLY ASP ILE ILE VAL PHE GLN LYS ASP ASP PRO GLU ASN SEQRES 18 A 548 ASP ASN SER GLU LEU PRO THR ALA LYS GLU TYR PHE ARG SEQRES 19 A 548 ASP LEU TYR HIS ARG VAL ASP VAL ILE PHE CYS ASP LYS SEQRES 20 A 548 THR ILE PRO ASN ASP PRO GLY PHE VAL VAL THR LEU SER SEQRES 21 A 548 ASN ARG MET ASN TYR PHE GLN VAL ALA LYS THR VAL ALA SEQRES 22 A 548 GLN ARG LEU ASN THR ASP PRO MET LEU LEU GLN PHE PHE SEQRES 23 A 548 LYS SER GLN GLY TYR ARG ASP GLY PRO GLY ASN PRO LEU SEQRES 24 A 548 ARG HIS ASN TYR GLU GLY THR LEU ARG ASP LEU LEU GLN SEQRES 25 A 548 PHE PHE LYS PRO ARG GLN PRO LYS LYS LEU TYR TYR GLN SEQRES 26 A 548 GLN LEU LYS MET LYS ILE THR ASP PHE GLU ASN ARG ARG SEQRES 27 A 548 SER PHE LYS CYS ILE TRP LEU ASN SER GLN PHE ARG GLU SEQRES 28 A 548 GLU GLU ILE THR LEU TYR PRO ASP LYS HIS GLY CYS VAL SEQRES 29 A 548 ARG ASP LEU LEU GLU GLU CYS LYS LYS ALA VAL GLU LEU SEQRES 30 A 548 GLY GLU LYS ALA SER GLY LYS LEU ARG LEU LEU GLU ILE SEQRES 31 A 548 VAL SER TYR LYS ILE ILE GLY VAL HIS GLN GLU ASP GLU SEQRES 32 A 548 LEU LEU GLU CYS LEU SER PRO ALA THR SER ARG THR PHE SEQRES 33 A 548 ARG ILE GLU GLU ILE PRO LEU ASP GLN VAL ASP ILE ASP SEQRES 34 A 548 LYS GLU ASN GLU MET LEU VAL THR VAL ALA HIS PHE HIS SEQRES 35 A 548 LYS GLU VAL PHE GLY THR PHE GLY ILE PRO PHE LEU LEU SEQRES 36 A 548 ARG ILE HIS GLN GLY GLU HIS PHE ARG GLU VAL MET LYS SEQRES 37 A 548 ARG ILE GLN SER LEU LEU ASP ILE GLN GLU LYS GLU PHE SEQRES 38 A 548 GLU LYS PHE LYS PHE ALA ILE VAL MET MET GLY ARG HIS SEQRES 39 A 548 GLN TYR ILE ASN GLU ASP GLU TYR GLU VAL ASN LEU LYS SEQRES 40 A 548 ASP PHE GLU PRO GLN PRO GLY ASN MET SER HIS PRO ARG SEQRES 41 A 548 PRO TRP LEU GLY LEU ASP HIS PHE ASN LYS ALA PRO LYS SEQRES 42 A 548 ARG SER ARG TYR THR TYR LEU GLU LYS ALA ILE LYS ILE SEQRES 43 A 548 HIS ASN HET EIB A1201 33 HETNAM EIB [(3S,3AR,4R,6Z,9S,10E,11AR)-9-ACETYLOXY-6- HETNAM 2 EIB (ACETYLOXYMETHYL)-3,10-DIMETHYL-2-OXIDANYLIDENE-3A,4, HETNAM 3 EIB 5,8,9,11A-HEXAHYDRO-3H-CYCLODECA[B]FURAN-4-YL] (E)-2- HETNAM 4 EIB METHYL-4-OXIDANYL-BUT-2-ENOATE HETSYN EIB BOUND FORM OF EUPALINOLIDE B FORMUL 2 EIB C24 H32 O9 FORMUL 3 HOH *29(H2 O) HELIX 1 AA1 GLU A 560 HIS A 562 5 3 HELIX 2 AA2 ASP A 573 CYS A 576 5 4 HELIX 3 AA3 SER A 601 GLY A 614 1 14 HELIX 4 AA4 PRO A 616 ASP A 618 5 3 HELIX 5 AA5 ASP A 639 GLY A 644 1 6 HELIX 6 AA6 THR A 647 ASP A 653 1 7 HELIX 7 AA7 LYS A 712 ASP A 715 5 4 HELIX 8 AA8 LEU A 716 GLY A 725 1 10 HELIX 9 AA9 SER A 752 LEU A 757 1 6 HELIX 10 AB1 ASP A 772 SER A 778 5 7 HELIX 11 AB2 THR A 782 HIS A 792 1 11 HELIX 12 AB3 ASN A 818 ASN A 831 1 14 HELIX 13 AB4 ASP A 833 MET A 835 5 3 HELIX 14 AB5 THR A 860 GLN A 866 1 7 HELIX 15 AB6 LYS A 884 ARG A 891 1 8 HELIX 16 AB7 CYS A 917 LYS A 927 1 11 HELIX 17 AB8 LEU A 958 LEU A 962 5 5 HELIX 18 AB9 PRO A 976 VAL A 980 5 5 HELIX 19 AC1 HIS A 1016 ASP A 1029 1 14 HELIX 20 AC2 GLN A 1031 GLU A 1036 1 6 HELIX 21 AC3 ASN A 1059 PHE A 1063 5 5 SHEET 1 AA1 5 THR A 592 LEU A 597 0 SHEET 2 AA1 5 TYR A 564 ALA A 571 -1 N ILE A 569 O THR A 592 SHEET 3 AA1 5 PRO A 657 THR A 664 1 O TRP A 658 N GLN A 566 SHEET 4 AA1 5 ILE A 620 ALA A 627 -1 N TRP A 623 O PHE A 661 SHEET 5 AA1 5 LYS A 633 PRO A 635 -1 O ARG A 634 N GLN A 626 SHEET 1 AA2 5 SER A 698 PRO A 708 0 SHEET 2 AA2 5 ASP A 684 ASP A 693 -1 N ASP A 693 O SER A 698 SHEET 3 AA2 5 ILE A 765 LYS A 770 1 O PHE A 768 N TYR A 692 SHEET 4 AA2 5 LEU A 732 LYS A 739 -1 N ILE A 733 O GLN A 769 SHEET 5 AA2 5 LEU A 742 ARG A 745 -1 O GLU A 744 N GLU A 736 SHEET 1 AA3 5 PHE A 809 SER A 814 0 SHEET 2 AA3 5 ARG A 793 ASP A 800 -1 N VAL A 794 O LEU A 813 SHEET 3 AA3 5 LYS A 875 GLN A 880 1 O LEU A 876 N ILE A 797 SHEET 4 AA3 5 LEU A 837 SER A 842 -1 N GLN A 838 O GLN A 879 SHEET 5 AA3 5 PRO A 849 LEU A 853 -1 O LEU A 853 N PHE A 839 SHEET 1 AA4 5 GLU A 905 LEU A 910 0 SHEET 2 AA4 5 PHE A 894 LEU A 899 -1 N PHE A 894 O LEU A 910 SHEET 3 AA4 5 THR A 969 GLU A 974 1 O PHE A 970 N ILE A 897 SHEET 4 AA4 5 LEU A 939 VAL A 945 -1 N ILE A 944 O THR A 969 SHEET 5 AA4 5 LYS A 948 HIS A 953 -1 O ILE A 950 N GLU A 943 SHEET 1 AA5 5 THR A1002 HIS A1012 0 SHEET 2 AA5 5 GLU A 987 PHE A 995 -1 N MET A 988 O ILE A1011 SHEET 3 AA5 5 TRP A1076 ASP A1080 1 O LEU A1079 N PHE A 995 SHEET 4 AA5 5 LYS A1039 MET A1044 -1 N ALA A1041 O GLY A1078 SHEET 5 AA5 5 ARG A1047 TYR A1050 -1 O ARG A1047 N MET A1044 LINK SG CYS A 576 CAT EIB A1201 1555 1555 1.84 CRYST1 78.005 80.170 150.857 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012820 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012473 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006629 0.00000